CA Patent

CA2708004C — Conjoint therapy for treating fibrotic diseases

Assigned to Promedior Inc · Expires 2015-12-01 · 10y expired

What this patent protects

The present invention relates to improved methods of treating fibrotic or fibroproliferative disorders. Conjoint ther-apies are provided comprising the combination of one or more fibrocyte suppressors and one or more profibrotic factor antagonists or anti- fibrotic agents.

USPTO Abstract

The present invention relates to improved methods of treating fibrotic or fibroproliferative disorders. Conjoint ther-apies are provided comprising the combination of one or more fibrocyte suppressors and one or more profibrotic factor antagonists or anti- fibrotic agents.

Drugs covered by this patent

Patent Metadata

Patent number: CA2708004C
Jurisdiction: CA
Classification: —
Expires: 2015-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Promedior Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.